The U.S. Department of Justice alleged that UCLA’s David Geffen School of Medicine “intentionally selected applicants based on their race,” citing violations of civil-rights law after the Supreme Court’s 2023 ban on race-conscious admissions. DOJ’s findings letter claims the school illegally preferenced Black and Hispanic applicants and relied on application questions that effectively solicited race information. UCLA disputed the allegations, saying the admissions process is merit-based and grounded in a rigorous, comprehensive review. The finding increases pressure on UC system leadership as the administration expands investigations into medical and higher-education admissions practices. The dispute also connects to broader litigation and compliance strategy across universities that must navigate Supreme Court constraints while addressing diversity-related goals through permissible, non-race-based considerations.